Avatar 1Avatar 2Avatar 3Avatar 4Avatar 5

Earn 10$ Cash for every Pro+ Friend you Refer!

Altimmune Inc

Altimmune Inc

ALT · NASDAQ
ALT · NASDAQ
2.74
USD-0.18-6.02%

Latest News

    CoinOtag

    US Banks Are Delaying the Genius Act: Agora and ALT

      CoinOtag

      Talkie-1930: The AI Deaf to Crypto and ALT Analysis

        CoinOtag

        35% of the Web is AI: Stanford Research and ALT Effect

          CoinOtag

          Web %35 AI Content: ALT Technical Outlook

            CoinOtag

            AI Fake Wolf Photo Led to Arrest: Neukgu and ALT

              CoinOtag

              Anthropic Claude Election Precautions and ALT Effect

              Analysts Recommendations

              Bullish

              Buy

              Strong Buy

              Buy

              Hold

              Sell

              Strong Sell

              Day Range

              2.73USD
              2.84USD

              52 Week Range

              2.56USD
              7.73USD

              Market Cap

              544.53MUSD

              lock-imagelock-image

              Get Full Access with Profit PRO

              See which Billionaires own this investment

              About

              General Information

              Type

              Common Stock

              Exchange

              NASDAQ

              Currency Code

              USD

              Currency Name

              US Dollar

              Country Name

              USA

              Country ISO

              US

              ISIN

              US02155H2004

              CUSIP

              42224H203

              Sector

              Healthcare

              Industry

              Biotechnology

              Fiscal Year End

              December

              IPO date

              -

              Updated At

              -

              Highlights

              PE Ratio

              -

              PEG Ratio

              32.62

              Book Value

              2.18

              Dividend Share

              -

              Dividend Yield

              -

              Earnings Share

              -0.92

              Wall Street Target Price

              16.06

              EPS Estimate Current Year

              -0.74

              EPS Estimate Next Year

              -0.90

              EPS Estimate Current Quarter

              -0.25

              EPS Estimate Next Quarter

              -0.2486

              Most Recent Quarter

              -

              Profitability

              Revenue TTM

              36,000

              Gross Profit TTM

              -66,052,000

              EBITDA

              -96,103,000

              Profit Margin

              0.00%

              Return On Assets TTM

              -24.40%

              Return On Equity TTM

              -42.75%

              Revenue Per Share TTM

              0

              Qtly Revenue Growth YOY

              420.00%

              Diluted Eps TTM

              -0.92

              Qtly Earnings Growth YOY

              0.00%

              Valuation

              Trailing PE

              0.00

              Forward PE

              8

              Price Sales TTM

              15206.8

              Price Book MRQ

              1.9551

              Enterprise Value Revenue

              7209

              Enterprise Value EBITDA

              11

              Peers analysis

              • UCB SA
                UCBJFUCB SA

                283.89

                3.04%
              • UCB SA ADR
                UCBJYUCB SA ADR

                136.01

                1.42%
              • CSL Ltd
                CSLLYCSL Ltd

                17.40

                0.75%
              • Alnylam Pharmaceuticals Inc
                ALNYAlnylam Pharmaceuticals Inc

                294.30

                0.33%
              • argenx SE
                ARGNFargenx SE

                803.19

                0.00%
              • Regeneron Pharmaceuticals Inc
                REGNRegeneron Pharmaceuticals Inc

                630.30

                -11.57%
              • Vertex Pharmaceuticals Inc
                VRTXVertex Pharmaceuticals Inc

                434.31

                -3.61%
              • argenx NV ADR
                ARGXargenx NV ADR

                797.77

                -2.91%
              • Revolution Medicines Inc
                RVMDRevolution Medicines Inc

                147.30

                -1.49%
              • CSL Limited
                CMXHFCSL Limited

                68.51

                -0.71%
              XM

              Trade Stocks with $30 Free + Double your Deposits with a 100% Bonus

              Trade with a Trusted, Award-Winning Broker.

              Trading involves risk. The value of investments may go up or down. Trade responsibly.

              FAQs

              What is Altimmune stock price today?

              What is Altimmune stock ticker?

              Is ALT stock price going up?

              What is the analyst recommendation for ALT?

              What is ALT market cap?

              Does ALT release financial reports?

              When is ALT next earnings date?

              What were ALT Earnings for the last quarter?

              What was ALT Revenue for the last quarter?

              What was ALT Net Income for the last quarter?

              Does ALT pay dividends?

              How many employees does ALT have?

              What is ALT EBITDA?

              How to buy ALT stocks?

              Should I invest in ALT stock?